OBJECTIVES: The appropriate approach for surgical repair of coarctation of the aorta with a ventricular septal defect (VSD) remains controversial. This study evaluated the outcomes of primary repair of VSDs with periventricular device closure without cardiopulmonary bypass through a left thoracotomy in patients without arch hypoplasia. METHODS: We selected 21 patients aged <1 year, including 7 neonates, who underwent repair of coarctation of the aorta with periventricular device closure of a VSD. RESULTS: The median occluder size was 6 (range, 5-8) mm. The median mechanical ventilation time was 14 (range, 2-68) h, and the median duration of hospital stay was 11 (range, 7-16) days. No reoperations were required to correct VSD shunting, and the median residual shunt size was 1 (range, 1-2) mm. The median follow-up period was 13 (range, 4-31) months. No late deaths were reported, and no haemodynamically significant pressure gradient at the anastomotic site was observed. The median distal aortic arch z-score was 0.39 (range, -0.1-to 0.9). Only 1 patient had a permanent pacemaker implanted towards the end of the follow-up period. CONCLUSIONS: Periventricular device closure can be used safely for closure of VSD in children with coarctation of the aorta without a hypoplastic aortic arch, even in neonates, to reduce the risk of prolonged cardiopulmonary bypass. This hybrid approach can be performed with a low incidence of rhythm disturbances and residual shunting. However, a meticulous assessment of the VSD anatomy is essential to avoid any unfavourable events.
OBJECTIVES: The appropriate approach for surgical repair of coarctation of the aorta with a ventricular septal defect (VSD) remains controversial. This study evaluated the outcomes of primary repair of VSDs with periventricular device closure without cardiopulmonary bypass through a left thoracotomy in patients without arch hypoplasia. METHODS: We selected 21 patients aged <1 year, including 7 neonates, who underwent repair of coarctation of the aorta with periventricular device closure of a VSD. RESULTS: The median occluder size was 6 (range, 5-8) mm. The median mechanical ventilation time was 14 (range, 2-68) h, and the median duration of hospital stay was 11 (range, 7-16) days. No reoperations were required to correct VSD shunting, and the median residual shunt size was 1 (range, 1-2) mm. The median follow-up period was 13 (range, 4-31) months. No late deaths were reported, and no haemodynamically significant pressure gradient at the anastomotic site was observed. The median distal aortic arch z-score was 0.39 (range, -0.1-to 0.9). Only 1 patient had a permanent pacemaker implanted towards the end of the follow-up period. CONCLUSIONS: Periventricular device closure can be used safely for closure of VSD in children with coarctation of the aorta without a hypoplastic aortic arch, even in neonates, to reduce the risk of prolonged cardiopulmonary bypass. This hybrid approach can be performed with a low incidence of rhythm disturbances and residual shunting. However, a meticulous assessment of the VSD anatomy is essential to avoid any unfavourable events.
Coarctation of the aorta (CoAo) is frequently associated with septal defects in neonates and infants. However, the appropriate approach for its surgical repair remains controversial. Most centres prefer a single-stage repair under cardiopulmonary bypass (CPB) with simultaneous closure of the septal defects [1, 2]. Aortic arch reconstruction under CPB with hypothermia is necessary in patients with aortic arch hypoplasia, but small patients are vulnerable to the effects of prolonged CPB time and myocardial ischaemia. Therefore, various perfusion methods are used to minimize CPB-induced complications during repair [3-5]. Repair through a left thoracotomy with or without palliative pulmonary artery banding can be performed in some patients with CoAo without arch hypoplasia. A hybrid approach with periventricular device closure (PVDC) of the ventricular septal defect (VSD) could also be an option for some patients to avoid CPB for primary repair.We present our experience with the hybrid approach of aortic arch reconstruction with PVDC of VSD for the treatment of complex CoAo.
PATIENTS AND METHODS
Ethical statement
The ethics committee of the E. Meshalkin National Medical Research Center approved this study. Informed consent was obtained from patients’ parents or guardians.
Participants
We retrospectively evaluated the medical records of >200 patients with obstructive aortic arch lesions who underwent surgery at the Novosibirsk National Medical Research Center from January 2014 to December 2019. A total of 21 patients (12 boys and 9 girls; 7 neonates) were included in the study according to the inclusion criteria (Fig. 1). We included patients aged <1 year with CoAo without severe aortic arch hypoplasia with perimembranous or muscular VSD sized <7 mm that was suitable for device closure. Patients with severe aortic arch hypoplasia (transverse arch z-score < −2.0) or interrupted aortic arch, large VSDs (>7 mm), inlet-type VSDs or concomitant intracardiac lesions (large atrial septal defects, multiple VSDs, subvalvular aortic stenosis and aortic valve stenosis) were excluded from the analysis.
Figure 1:
Flow chart of the selection of patients with coarctation of the aorta for retrospective analysis. CoAo: coarctation of the aorta; CPB: cardiopulmonary bypass; PAB: pulmonary artery banding; PVDC: periventricular device closure; VSD: ventricular septal defect.
Flow chart of the selection of patients with coarctation of the aorta for retrospective analysis. CoAo: coarctation of the aorta; CPB: cardiopulmonary bypass; PAB: pulmonary artery banding; PVDC: periventricular device closure; VSD: ventricular septal defect.
Surgical technique
Aortic arch hypoplasia was assessed using the z-score (Peterson’s calculator) [6]. CoAo without arch hypoplasia or with only distal arch hypoplasia (distal arch z-score < −2.0; transverse aortic arch z-score > −2.0) was considered for extended end-to-end anastomosis without CPB.CoAo repair was performed through a posterolateral thoracotomy in the third intercostal space. The isthmus, descending aorta and aortic arch with brachiocephalic vessels were dissected. The ductus arteriosus was ligated, and the aorta was closed with Satinsky clamps. Next, the isthmus with ductal tissue was resected, and an extended end-to-end anastomosis was performed.When single-stage repair with PVDC was considered, a ministernotomy was performed in most patients (18 patients); in 3 patients, PVDC was performed through a left lateral thoracotomy, extending it anteriorly to visualize the RV wall (the RV wall was lifted with the forceps to find the proper puncture site). The right ventricle was punctured opposite the VSD under transoesophageal echocardiography monitoring. A guidewire was introduced into the left ventricle through the VSD, and a MemoPart VSD occlusion device (Lepu Medical Technology, Shanghai Shape Memory Allow Co., Ltd., Shanghai, China) of appropriate size (VSD size + 1 mm) was placed in a stepwise manner.
Statistical methods
The Shapiro–Wilk W-test was performed to assess the normality of continuous variables before further analysis. Continuous data are presented as medians and ranges. Categorical data are presented as rates and frequencies. Statistical analyses were performed using Stata 13 (StataCorp LP, College Station, TX, USA).
RESULTS
The baseline characteristics are presented in Table 1. No in-hospital deaths were reported. The median occluder size was 6 (5–8) mm. Seven patients in the cohort were neonates.
Table 1:
Baseline characteristics
Parameter
n = 21
Gender
Female
9 (42.8%)
Male
12 (57.1%)
Age, days
71.1 (20–320)
Weight, kg
4.8 (3.4–11.2)
Neonates, n (%)
7 (33.3)
Z-score of aortic isthmus
−4.9 (−5.79–−4.75)
Z-score, distal aortic arch
−1.66 (−1.81–−1.26)
Device size, mm
6 (5–8)
Device type, n
I
4
II
10
IV
7
Baseline characteristicsOne patient presented with temporary atrioventricular (AV) conduction disorder (second-degree AV block, Mobitz type I), which was resolved on the third postoperative day after glucocorticosteroid and dobutamine drug therapy in the intensive care unit. No other significant rhythm disturbances were noted.The median mechanical ventilation time was 14 (2–68) h. The postoperative results are presented in Table 2. The median follow-up period was 13 (4–31) months. No late deaths were reported (Table 2). No haemodynamically significant pressure gradient was observed at the anastomotic site, and the median distal aortic arch z-score was 0.39 (−0.1–0.9). No reoperations were required to correct VSD shunting, and the median residual shunt size was 1 (1–2) mm.
Table 2:
Postoperative data
Parameter
N = 21
Early deaths, %
0
Duration of mechanical ventilation, h
14 (2–68)
Hospital stay, days
11 (7–14)
Pressure gradient, mmHg
8.3 (6 –12)
Follow-up, months
13 (4–31)
Recoarctation rate, %
0
Residual VSD rate, n
4 (19)
Residual VSD shunt, mm
1 (1–2)
Rhythm disturbance, n
1 (4.3)
Z-score distal arch
0.39 (−0.1 to 0.9)
Survival, %
100
VSD: ventricular septal defect.
Postoperative dataVSD: ventricular septal defect.Only 1 patient presented with a rhythm disturbance 1 year postoperatively. He had a temporary second-degree AV block in the early postoperative period, which was reversed; a permanent pacemaker implant was recommended.
DISCUSSION
Surgical repair of VSD in infants is routinely performed under CPB with a low complication rate and few deaths. Although this method has been partially replaced by transcatheter device closure to improve clinical outcomes, the endovascular approach is limited by the vessel size and the anatomical features of the VSD [7]. PVDC, described by Amin et al. in 1998, is an increasingly used hybrid method that has no restrictions, unlike the percutaneous transcatheter method [8]. However, the risk of valve distortion or heart block is higher in small patients. Thus, the results of device closure are controversial. Our recent randomized study showed the suitability of this method in patients of any age [9]. Although few patients had transitory rhythm disturbances during the study, some of them returned with complete AV block and had a pacemaker implanted permanently. Some authors have mentioned that, in case of early complete AV block due to mechanical injury during manipulation of the delivery system or during device implant, conversion to open surgery should be considered [7, 10]. The cause of late-onset complete AV block remains unknown, but it probably occurs as a result of chronic inflammation and fibrosis due to the device, which is more likely to occur in infants with large defects.The simultaneous closure of VSD and atrial septal defects or patent ductus arteriosus has been reported [11, 12]. Our experience has shown that this method is safe and effective in treating congenital septal defects that do not require surgical repair under CPB. Indications for PVDC should not be overestimated because implanting a large device may lead to more severe complications than those of the conventional approach, such as aortic regurgitation, tricuspid regurgitation and rhythm disturbances. We used a cut-off VSD size ≤7 mm for PVDC in children. However, the VSD size should be correlated with the patient’s body surface area.CoAo repair in small patients often requires aortic reconstruction under CPB with deep hypothermia or selective cerebral perfusion for brain protection. However, this approach poses additional risks to the patient, such as renal injury and neurological events, that could compromise the postoperative recovery [5, 13, 14]. In some patients, CoAo without arch hypoplasia can be repaired through a left thoracotomy; however, the presence of VSD usually necessitates primary repair under CPB. We selected patients with perimembranous or large muscular VSD that required closure for CoAo and VSD repair using the hybrid approach. This method helps to avoid repair under CPB and a prolonged stay in the intensive care unit. However, the hybrid approach has some limitations that are related mainly to the patient’s body mass and VSD size. We did not include in this study the patients with VSDs with well-defined margins that are too large for PVDC, in whom we considered placing a band on the pulmonary trunk to allow the patient’s growth until the subsequent assessment. As one could see, only a few patients from the whole CoAo + VSD cohort underwent repair using PVDC. This method could be especially helpful for the closure of muscular VSDs in the mid-portion of the septum (Figs. 2, 3) with a low risk of residual shunting.
Figure 2:
Patient with (A) coarctation of the aorta and (B) muscular ventricular septal defect.
Figure 3:
Result of the hybrid approach. Computed tomography imaging showing (A) the aortic arch after extended end-to-end anastomosis and (B) showing the device in the ventricular septum.
Patient with (A) coarctation of the aorta and (B) muscular ventricular septal defect.Result of the hybrid approach. Computed tomography imaging showing (A) the aortic arch after extended end-to-end anastomosis and (B) showing the device in the ventricular septum.
LIMITATIONS
The limitations of our analysis include its retrospective nature, the small number of cases reviewed and the short follow-up period (median was approximately 1 year). Although the intermediate-term follow-up results seem to be satisfactory, it is necessary to assess long-term rhythm disturbance rates. This study did not include a comparison group, and further studies with a control group are required to assess the effectiveness of PVDC.
CONCLUSIONS
PVDC can be used safely for closure of VSD in children with CoAo without a hypoplastic aortic arch, even in neonates, to reduce the risk of prolonged CPB. This hybrid approach can be performed with a low incidence of rhythm disturbances and residual shunting; however, a meticulous assessment of the VSD anatomy is essential to avoid any unfavourable events. Further studies are required to define the best candidates for this approach.
FUNDING
This study did not receive any specific financial support from funding agencies in the public, commercial or not-for-profit sectors.Conflict of interests: none declared.
Data availability
The data underlying this article are available in the article.
Authors: James M Hammel; Joseph J Deptula; Tara Karamlou; Elesa Wedemeyer; Ibrahim Abdullah; Kim F Duncan Journal: Ann Thorac Surg Date: 2013-08-30 Impact factor: 4.330
Authors: Selma O Algra; Nicolaas J G Jansen; Ingeborg van der Tweel; Antonius N J Schouten; Floris Groenendaal; Mona Toet; Wim van Oeveren; Ingrid C van Haastert; Paul H Schoof; Linda S de Vries; Felix Haas Journal: Circulation Date: 2013-10-20 Impact factor: 29.690
Authors: Yuriy Y Kulyabin; Yuriy N Gorbatykh; Ilya A Soynov; Alexey V Zubritskiy; Alexey V Voitov; Alexander V Bogachev-Prokophiev Journal: World J Pediatr Congenit Heart Surg Date: 2020-01